June 1, 2018 05:57 PM EDTUpdated June 4, 02:54 PM

Bluebird, Celgene add a promising chapter to their success story with BCMA-targeting CAR-T — and turn it around with investors

CHICAGO — Right now at Celgene $CELG and bluebird $BLUE, it’s all about the KarMMa — and they’re looking to burnish theirs at ASCO. …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Blue­bird, Cel­gene add a promis­ing chap­ter to their suc­cess sto­ry with BC­MA-tar­get­ing CAR-T — and turn it around with in­vestors